Ask AI
Bill115th CongressFiled May 11, 2017Health
H.R. 2410

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary passed house without amendment (Feb 26, 2018)

(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.

(Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.

What just happenedFeb 27, 2018

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Rep. Davis, Danny K. [D-IL-7](D-IL)Sponsor
2 cosponsors1 D1 R
Read on Congress.gov
2cosponsors2committees18actions3related bills9subjects
  1. Feb 27, 2018IntroReferral

    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. Feb 26, 2018FloorH38310

    Motion to reconsider laid on the table Agreed to without objection.

  3. Feb 26, 2018FloorH37300

    On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1240-1241)

  4. Feb 26, 2018Floor8000

    Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1240-1241)

  5. Feb 26, 2018FloorH8D000

    DEBATE - The House proceeded with forty minutes of debate on H.R. 2410.

  6. Feb 26, 2018FloorH30000

    Considered under suspension of the rules. (consideration: CR H1240-1243)

  7. Feb 26, 2018FloorH30300

    Mr. Burgess moved to suspend the rules and pass the bill.

  8. Oct 19, 2017CalendarsH12410

    Placed on the Union Calendar, Calendar No. 258.

  9. Oct 19, 2017CommitteeH12200

    Reported by the Committee on Energy and Commerce. H. Rept. 115-354.

    Energy and Commerce Committee
  10. Oct 19, 2017Committee5000

    Reported by the Committee on Energy and Commerce. H. Rept. 115-354.

    Energy and Commerce Committee
  11. Jun 7, 2017Committee

    Ordered to be Reported by Voice Vote.

    Energy and Commerce Committee
  12. Jun 7, 2017Committee

    Committee Consideration and Mark-up Session Held.

    Energy and Commerce Committee
  13. May 18, 2017Committee

    Forwarded by Subcommittee to Full Committee by Voice Vote .

    Health Subcommittee
  14. May 18, 2017Committee

    Subcommittee Consideration and Mark-up Session Held.

    Health Subcommittee
  15. May 12, 2017Committee

    Referred to the Subcommittee on Health.

    Health Subcommittee
  16. May 11, 2017IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

    Energy and Commerce Committee
  17. May 11, 2017IntroReferralIntro-H

    Introduced in House

  18. May 11, 2017IntroReferral1000

    Introduced in House

Passed House without amendmentFeb 26, 201881

(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.

(Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
Reported to House without amendmentOct 19, 201779

(This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.

(Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
Introduced in HouseMay 11, 2017

Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications.

The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 — Informed